222 related articles for article (PubMed ID: 29313589)
1. Role of Clarithromycin in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Vora A
J Assoc Physicians India; 2017 Sep; 65(9):100-104. PubMed ID: 29313589
[TBL] [Abstract][Full Text] [Related]
2. Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
Simoens S; Laekeman G; Decramer M
Respir Med; 2013 May; 107(5):637-48. PubMed ID: 23352223
[TBL] [Abstract][Full Text] [Related]
3. Macrolide effects on the prevention of COPD exacerbations.
Yamaya M; Azuma A; Takizawa H; Kadota J; Tamaoki J; Kudoh S
Eur Respir J; 2012 Aug; 40(2):485-94. PubMed ID: 22408201
[TBL] [Abstract][Full Text] [Related]
4. [LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
Shteinberg M; Schneer S; Lavon O; Adir Y
Harefuah; 2016 Sep; 155(9):567-571. PubMed ID: 28530085
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease.
Donath E; Chaudhry A; Hernandez-Aya LF; Lit L
Respir Med; 2013 Sep; 107(9):1385-92. PubMed ID: 23768735
[TBL] [Abstract][Full Text] [Related]
6. Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro.
Marjanović N; Bosnar M; Michielin F; Willé DR; Anić-Milić T; Culić O; Popović-Grle S; Bogdan M; Parnham MJ; Eraković Haber V
Pharmacol Res; 2011 May; 63(5):389-97. PubMed ID: 21315154
[TBL] [Abstract][Full Text] [Related]
7. Macrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysis.
Yao GY; Ma YL; Zhang MQ; Gao ZC
Respiration; 2013; 86(3):254-60. PubMed ID: 23817204
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbations.
Simoens S; Decramer M; De Coster S; Celis G; Laekeman G
Int J Clin Pract; 2007 Feb; 61(2):200-6. PubMed ID: 17263707
[TBL] [Abstract][Full Text] [Related]
9. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.
Berim I; Sethi S
Ther Adv Respir Dis; 2011 Jun; 5(3):207-16. PubMed ID: 21378062
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.
Schembri S; Williamson PA; Short PM; Singanayagam A; Akram A; Taylor J; Singanayagam A; Hill AT; Chalmers JD
BMJ; 2013 Mar; 346():f1235. PubMed ID: 23525864
[TBL] [Abstract][Full Text] [Related]
11. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.
Basyigit I; Yildiz F; Ozkara SK; Yildirim E; Boyaci H; Ilgazli A
Ann Pharmacother; 2004 Sep; 38(9):1400-5. PubMed ID: 15252191
[TBL] [Abstract][Full Text] [Related]
12. Macrolide therapy for the prevention of acute exacerbations in chronic obstructive pulmonary disease.
Mammen MJ; Sethi S
Pol Arch Med Wewn; 2012; 122(1-2):54-9. PubMed ID: 22353707
[TBL] [Abstract][Full Text] [Related]
13. COPD: management of acute exacerbations and chronic stable disease.
Hunter MH; King DE
Am Fam Physician; 2001 Aug; 64(4):603-12. PubMed ID: 11529259
[TBL] [Abstract][Full Text] [Related]
14. Use of long-term macrolide therapy in chronic obstructive pulmonary disease.
Ramos FL; Criner GJ
Curr Opin Pulm Med; 2014 Mar; 20(2):153-8. PubMed ID: 24378875
[TBL] [Abstract][Full Text] [Related]
15. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
[TBL] [Abstract][Full Text] [Related]
16. Inhalation of macrolides: a novel approach to treatment of pulmonary infections.
Siekmeier R; Hofmann T; Scheuch G
Adv Exp Med Biol; 2015; 839():13-24. PubMed ID: 25252902
[TBL] [Abstract][Full Text] [Related]
17. [Effects of mucolytic agents and macrolides in the treatment of COPD].
Yamaya M
Nihon Rinsho; 2016 May; 74(5):833-8. PubMed ID: 27254955
[TBL] [Abstract][Full Text] [Related]
18. Prevention of exacerbations of COPD with pharmacotherapy.
Miravitlles M
Eur Respir Rev; 2010 Jun; 19(116):119-26. PubMed ID: 20956180
[TBL] [Abstract][Full Text] [Related]
19. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
[TBL] [Abstract][Full Text] [Related]
20. Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease.
Black PN; McDonald CF
Postgrad Med J; 2009 Mar; 85(1001):141-7. PubMed ID: 19351641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
